![Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Australia Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Australia](https://www.ypsomed.com/files/media/02_Images/09_Press_Releases/Ajovy_Pen_CMYK_DE_ohneSchatten_low.png)
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Australia
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder](https://mms.businesswire.com/media/20200921005170/en/819864/4/Interactive_Media_Placeholder_webready.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
![Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook | Business Wire Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook | Business Wire](https://mms.businesswire.com/media/20230510005122/en/1789379/4/Infographic_Q1_2023.jpg)